GlassScriptPhysician profile
Laura E Osoba
NPI 1487051579
$3,335.02
in general payments reported to CMS, 2019-2025
10 companies · $1,150 in 2025
The $1,150 reported for 2025 was more than what 91% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.61 · 2022: $701 · 2023: $984 · 2024: $473 · 2025: $1,150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,629 · Honoraria: $500 · Travel and Lodging: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,629.37 |
| Honoraria | $500.00 |
| Travel and Lodging | $478.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $1,924.51 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Atricure, INC. | $513.40 | 2022-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $222.45 | 2023-2025 | |
| Abiomed | $211.11 | 2025 | |
| Abbott Laboratories | $188.99 | 2022-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Maquet Cardiovascular L.L.C. | $153.53 | 2024-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Baxter Healthcare | $42.85 | 2023-2024 | Floseal, Preveleak |
| Briohealth Solutions, INC. | $31.05 | 2025 | Briovad |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.63 | 2022 | |
| Medtronic, INC. | $22.50 | 2025 | Vitalflow Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Osoba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.